Question 1

Does Citadel Advisors own SLDBN stock?

Accepted Answer

No. Citadel Advisors exited its SLDBN (Solid Biosciences) position in Q3 2022. Its Q2 2022 13F listed 70,242 shares worth $44,000.

Question 2

How many shares of SLDBN does Citadel Advisors own?

Accepted Answer

None since Q3 2022, when Citadel Advisors exited the position. Its Q2 2022 13F listed 70,242 shares worth $44,000.

Question 3

What is Citadel Advisors' SLDBN position worth?

Accepted Answer

Citadel Advisors' SLDBN position was worth $44,000 in its Q2 2022 13F, before the exit in Q3 2022.

Question 4

Is Citadel Advisors buying or selling SLDBN?

Accepted Answer

In Q3 2022, Citadel Advisors exited its entire SLDBN position.

Question 5

When did Citadel Advisors first buy SLDBN?

Accepted Answer

Citadel Advisors first reported SLDBN in its Q1 2019 13F and listed it in 14 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2022-Q3 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2022-Q2	Increased	70,242	+577.9%	$44,000	0.0%	—	22
2022-Q1	Decreased	10,362	-85.0%	$12,000	0.0%	—	0
2021-Q4	Increased	68,960	+238.6%	$121,000	0.0%	—	24
2021-Q3	Decreased	20,366	-44.6%	$49,000	0.0%	—	0
2021-Q2	Decreased	36,742	-98.5%	$134,000	0.0%	—	0
2021-Q1	Increased	2.5M	+9487.1%	$13.8M	0.0%	—	45
2020-Q4	Increased	26,116	+49.7%	$198,000	0.0%	—	32
2020-Q3	Decreased	17,449	-85.8%	$35,000	0.0%	—	0
2020-Q2	Increased	122,634	+52.8%	$359,000	0.0%	—	33
2020-Q1	Decreased	80,259	-59.8%	$192,000	0.0%	—	0
2019-Q4	Decreased	199,476	-45.4%	$888,000	0.0%	—	0
2019-Q3	Increased	365,132	+90.5%	$3.8M	0.0%	—	42
2019-Q2	Decreased	191,620	-63.2%	$1.1M	0.0%	—	0
2019-Q1	New	520,386	-	$4.8M	0.0%	—	37